Lemaitre Vascular Overview
- Year Founded
-
1983
- Status
-
Public
- Employees
-
630
- Stock Symbol
-
LMAT
- Investments
-
19
- Share Price
-
$86.07
- (As of Monday Closing)
Lemaitre Vascular General Information
Description
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches and vessel closure systems.It has a single operating segment engaged in the development, manufacturing, and marketing of medical devices and implants, as well as the processing and cryopreservation of human tissues for implantation in patients.
Contact Information
Website
www.lemaitre.comCorporate Office
- 63 Second Avenue
- Burlington, MA 01803
- United States
Corporate Office
- 63 Second Avenue
- Burlington, MA 01803
- United States
Lemaitre Vascular Stock Performance
As of 24-Mar-2025, Lemaitre Vascular’s stock price is $86.07. Its current market cap is $1.94B with 22.6M shares.
(As of Monday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $86.07 | $83.49 | $62.39 - $109.58 | $1.94B | 22.6M | 208K | $1.96 |
Lemaitre Vascular Financials Summary
As of 31-Dec-2024, Lemaitre Vascular has a trailing 12-month revenue of $220M.
|
In Thousands, USD |
TTM 31-Dec-2024 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
|---|---|---|---|---|
| EV | 1,966,115 | 1,966,115 | 1,183,524 | 949,466 |
| Revenue | 219,863 | 219,863 | 193,484 | 161,651 |
| EBITDA | 61,801 | 61,801 | 45,913 | 35,937 |
| Net Income | 44,038 | 44,038 | 30,105 | 20,636 |
| Total Assets | 551,817 | 551,817 | 346,778 | 310,476 |
| Total Debt | 185,685 | 185,685 | 19,095 | 16,596 |
Lemaitre Vascular Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Lemaitre Vascular Comparisons
Industry
Financing
Details
Lemaitre Vascular Competitors (19)
One of Lemaitre Vascular’s 19 competitors is Angiodynamics, a Private Debt Financed company based in Latham, NY.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Angiodynamics | Private Debt Financed | Latham, NY | ||||
| Penumbra | Formerly VC-backed | Alameda, CA | ||||
| Okami Medical | Venture Capital-Backed | Aliso Viejo, CA | ||||
| Lombard Medical | Formerly PE-Backed | Didcot, United Kingdom | ||||
| Access Vascular | Venture Capital-Backed | Billerica, MA |
Lemaitre Vascular Patents
Lemaitre Vascular Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-2663247-A1 | Systems and methods for remote endarterectomy | Inactive | 14-Jan-2011 | ||
| CA-2824061-A1 | Systems and methods for remote endarterectomy | Inactive | 14-Jan-2011 | ||
| AU-2012205353-A1 | Systems and methods for remote endarterectomy | Inactive | 14-Jan-2011 | ||
| US-20160100855-A1 | Over-the-wire-valvulotomes | Inactive | 22-Jun-2010 | ||
| EP-2473121-B1 | Over-the-wire valvulotomes | Inactive | 22-Jun-2010 | A61B17/320725 |
Lemaitre Vascular Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Lemaitre Vascular Investments & Acquisitions (19)
Lemaitre Vascular’s most recent deal was a Merger/Acquisition with Prompt Serve for . The deal was made on 14-Mar-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Prompt Serve | 14-Mar-2023 | Merger/Acquisition | Distributors (Healthcare) | ||
| Lombard Medical (Aorfix an Endovascular Stent Graft in Burlington, Vermont) | 01-Jan-2023 | Corporate Asset Purchase | Buildings and Property | ||
| Artegraft | 22-Jun-2020 | Merger/Acquisition | Therapeutic Devices | ||
| Admedus (Biologic Patch Business) | 11-Oct-2019 | Merger/Acquisition | Surgical Devices | ||
| Cardial | 22-Oct-2018 | Merger/Acquisition |
Lemaitre Vascular ESG
Risk Overview
Risk Rating
Updated March, 01, 2025
30.94 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 14,946
Rank
Percentile
Healthcare
Industry
of 581
Rank
Percentile
Medical Devices
Subindustry
of 196
Rank
Percentile
Lemaitre Vascular Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Artegraft | North Brunswick, NJ | 1993 |
Lemaitre Vascular FAQs
-
When was Lemaitre Vascular founded?
Lemaitre Vascular was founded in 1983.
-
Where is Lemaitre Vascular headquartered?
Lemaitre Vascular is headquartered in Burlington, MA.
-
What is the size of Lemaitre Vascular?
Lemaitre Vascular has 630 total employees.
-
What industry is Lemaitre Vascular in?
Lemaitre Vascular’s primary industry is Other Devices and Supplies.
-
Is Lemaitre Vascular a private or public company?
Lemaitre Vascular is a Public company.
-
What is Lemaitre Vascular’s stock symbol?
The ticker symbol for Lemaitre Vascular is LMAT.
-
What is the current stock price of Lemaitre Vascular?
As of 24-Mar-2025 the stock price of Lemaitre Vascular is $86.07.
-
What is the current market cap of Lemaitre Vascular?
The current market capitalization of Lemaitre Vascular is $1.94B.
-
What is Lemaitre Vascular’s current revenue?
The trailing twelve month revenue for Lemaitre Vascular is $220M.
-
Who are Lemaitre Vascular’s competitors?
Angiodynamics, Penumbra, Okami Medical, Lombard Medical, and Access Vascular are some of the 19 competitors of Lemaitre Vascular.
-
What is Lemaitre Vascular’s annual earnings per share (EPS)?
Lemaitre Vascular’s EPS for 12 months was $1.96.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
